babs11 schreef:
"The RD-3 virus has passed internationally-agreed safety tests has been used to produce an inactivated vaccine on the PER.C6 mammalian cell line.
A clinical trial of the H7N1 vaccine will begin in September 2006.
Surveillance of wild and domestic birds in Italy has shown that influenza viruses from several different subtypes (including non-pathogenic H5 and H7) have been in circulation.
A modified serological test has been developed with increased sensitivity for detection of antibody to H5 and H7 influenza viruses. This test can be used in serosurveillance to provide early warning of a possible pandemic. It also will be useful in vaccine evaluation."